Loading clinical trials...
Loading clinical trials...
This study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with p...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Defense Medical Center, Taiwan
NCT06814145 · Hypertension, Pulmonary
NCT07075679 · Breast Cancer Screening, Artificial Intelligence (AI), and more
NCT07236840 · CNS Tumor, Artificial Intelligence (AI), and more
NCT07265427 · Digital Health, Artificial Intelligence (AI)
NCT06957093 · Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)
National Defense Medical Center
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions